Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids (MILLY)

This study has been completed.
Information provided by:
Genentech, Inc. Identifier:
First received: June 29, 2009
Last updated: June 30, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 30, 2011